Pathophysiology: Drug Classes assignment
By Day 1 of Week One, your instructor will post student assignments.
For each drug class, identify:
|
Drug Focus
|
Drug Class
|
| Drugs for coagulation disorders | Anticoagulants |
| Antiplatelet agents | |
| Thrombolytics | |
| Hemstatics | |
| Drugs for hypertension | Diuretics |
| Calcium channel blockers | |
| Renin-angiotensin pathway modifiers | |
| Adrenergic blockers | |
| Direct- acting vasodilators | |
| Drugs for heart failure | Cardiac glycosides |
| Angiotensin-converting enzyme (ACE) inhibitors | |
| Phosphodiesterase inhibitors | |
| Beta-adrenergic blockers | |
| Natriuetic peptides | |
| Drugs for dysrhythmias | Sodium channel blockers |
| Beta-adrenergic blockers | |
| Potassium channel blockers | |
| Calcium channel blockers | |
| Drugs for angina pectoris, myocardial infarction and cerebrovascular disorders |
Organic nitrates |
| Beta-adrenergic blockers | |
| Calcium channel blockers | |
| Thrombolytics | |
| H2-receptor blockers | |
| Proton-pump inhibitors | |
| Anorexiants | |
| Pancreatic enzyme replacement | |
| Antacids | |
| Drugs for pulmonary disorders | Beta-adrenergic agents |
| Xanthines | |
| Anticholinergics | |
| Glucocortocoids | |
| Mast cell stabilizers | |
| Leukotriene modifiers |
- One drug
- Provide the generic and brand name (usually capitalized)
- Drug class
- Route and dose
- Actions and uses
- Adverse reactions
- Mechanism in action
- Interactions
- Manufacturer
- Advertisement
- Is there a common print ad or commercial for the drug?
- Is there a theme in the print ad or commercial? For example, a phrase or setting to help the viewer remember the drug.)
In addition, does the drug company have any clinical studies underway for the drug? If so, summarize these studies.
Guided Response: Your paper should be one to two pages long, excluding the title and reference pages, and formatted according to APA guidelines as outlined by the Ashford Writing Center. You should use a minimum of two scholarly sources, excluding the textbook, to support your submission.
